Skip to Content

We are a biopharmaceutical company committed to the development and commercialization of innovative therapies for patients coping with serious unmet medical needs and life-limiting diseases.

Financial News

Access our recent and archived press releases. This section also provides a calendar of upcoming ecents and presentations.

View All

Earnings

Our investor relations portal provides access to our financial information, filings, presentations and stock information.

Visit Our Investor Tools

Our Products

Our growing pipeline of products is focused on advancing treatments for patients with serious unmet medical needs

Learn About Our Products